---
figid: PMC7936245__12882_2021_2257_Fig4_HTML
figlink: pmc/articles/PMC7936245/figure/Fig4/
number: F4
caption: Possible proximal tubule epithelial cell signals in glomerulonephritis and
  renal cell carcinoma. (1) Low levels of calcium induce the release of parathyroid
  hormone (PTH) from parathyroid glands and this stimulates renal CYP27B1 expression.
  (2) 25(OH)D3, formed in the liver, is hydroxylated by CYP27B1 to form the active
  metabolite, 1α-25(OH)2D3. (3) CYP24A1 catalyzes the conversion of 25(OH)D3 and 1α-25(OH)2D3
  into 24-hydroxylated products targeted for excretion. (4) Elevated levels of 1α-25(OH)2D3
  induce the production of fibroblast growth factor-23 (FGF-23), which suppresses
  CYP27B1 transcription. (5) 1α-25(OH)2D3 may antagonize PAMP/DAMP-induced inflammasome
  activation. (6) Vitamin D response elements (VDRE) in the PD-L1 gene may be functionally
  active in the renal epithelium. (7) PAMPs/DAMPs, ROS, and IL-1β activate PD-L1 transcription
  factors, HIF-1α and NF-kB. PD-L1 expression can be blocked with monoclonal antibodies.
  (8) 1α-25(OH)2D3 antagonizes Akt and the transcription factor STAT3 that may be
  induced by IL-6 and mTORC2. IL-6 receptor monoclonal antibodies block IL-6 signals.
  (9) Hypoxia promotes the stability and activation of HIF-1α and HIF-2α. Both mTORC1
  and mTORC2 are involved in HIF-1α regulation. mTORC2 regulates the expression of
  HIF-2α and is activated by VEGF cell signals. Tyrosine kinase inhibitors block VEGF
  receptor signals. (10) HIF-1α and HIF-2α induce the production of SDF-1 and VEGF.
  Antibodies that bind circulating VEGF block VEGF binding to its receptor. (11) Metformin-induced
  AMPK promotes PD-L1 phosphorylation and degradation. AMPK is also involved the phosphorylation
  of PGC-1α, which is additionally de-acetylated by sirtuins (SIRT1) during mitochondrial
  biogenesis and under conditions of normoxia. (12) Uric acid is a DAMP involved in
  the activation of the inflammasome and proximal tubule epithelial cell production
  of adiponectin. (13) Metformin and AICAR activate AMPK. Metformin therapy may induce
  the production of adiponectin. (14) γ-glutamyltransferase activity degrades glutathione
  (GSH) into its individual amino acids. (15) Reduced GSH scavenges free radicals
  and generates an oxidized form of GSH (GSSG). (16) GSH metabolism is associated
  with the activation of the pentose phosphate pathway. (17) NF-kB is antagonized
  by glucocorticoids and promotes the production of chemokines and ROS. (18) The cell
  signals that occur in response to PD-L1 ligation or blockade are not well characterized
pmcid: PMC7936245
papertitle: PD-1 immunobiology in glomerulonephritis and renal cell carcinoma.
reftext: Colleen S. Curran, et al. BMC Nephrol. 2021;22:80.
pmc_ranked_result_index: '122896'
pathway_score: 0.9352341
filename: 12882_2021_2257_Fig4_HTML.jpg
figtitle: Possible proximal tubule epithelial cell signals in glomerulonephritis and
  renal cell carcinoma
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7936245__12882_2021_2257_Fig4_HTML.html
  '@type': Dataset
  description: Possible proximal tubule epithelial cell signals in glomerulonephritis
    and renal cell carcinoma. (1) Low levels of calcium induce the release of parathyroid
    hormone (PTH) from parathyroid glands and this stimulates renal CYP27B1 expression.
    (2) 25(OH)D3, formed in the liver, is hydroxylated by CYP27B1 to form the active
    metabolite, 1α-25(OH)2D3. (3) CYP24A1 catalyzes the conversion of 25(OH)D3 and
    1α-25(OH)2D3 into 24-hydroxylated products targeted for excretion. (4) Elevated
    levels of 1α-25(OH)2D3 induce the production of fibroblast growth factor-23 (FGF-23),
    which suppresses CYP27B1 transcription. (5) 1α-25(OH)2D3 may antagonize PAMP/DAMP-induced
    inflammasome activation. (6) Vitamin D response elements (VDRE) in the PD-L1 gene
    may be functionally active in the renal epithelium. (7) PAMPs/DAMPs, ROS, and
    IL-1β activate PD-L1 transcription factors, HIF-1α and NF-kB. PD-L1 expression
    can be blocked with monoclonal antibodies. (8) 1α-25(OH)2D3 antagonizes Akt and
    the transcription factor STAT3 that may be induced by IL-6 and mTORC2. IL-6 receptor
    monoclonal antibodies block IL-6 signals. (9) Hypoxia promotes the stability and
    activation of HIF-1α and HIF-2α. Both mTORC1 and mTORC2 are involved in HIF-1α
    regulation. mTORC2 regulates the expression of HIF-2α and is activated by VEGF
    cell signals. Tyrosine kinase inhibitors block VEGF receptor signals. (10) HIF-1α
    and HIF-2α induce the production of SDF-1 and VEGF. Antibodies that bind circulating
    VEGF block VEGF binding to its receptor. (11) Metformin-induced AMPK promotes
    PD-L1 phosphorylation and degradation. AMPK is also involved the phosphorylation
    of PGC-1α, which is additionally de-acetylated by sirtuins (SIRT1) during mitochondrial
    biogenesis and under conditions of normoxia. (12) Uric acid is a DAMP involved
    in the activation of the inflammasome and proximal tubule epithelial cell production
    of adiponectin. (13) Metformin and AICAR activate AMPK. Metformin therapy may
    induce the production of adiponectin. (14) γ-glutamyltransferase activity degrades
    glutathione (GSH) into its individual amino acids. (15) Reduced GSH scavenges
    free radicals and generates an oxidized form of GSH (GSSG). (16) GSH metabolism
    is associated with the activation of the pentose phosphate pathway. (17) NF-kB
    is antagonized by glucocorticoids and promotes the production of chemokines and
    ROS. (18) The cell signals that occur in response to PD-L1 ligation or blockade
    are not well characterized
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CXCL8
  - CD274
  - ADIPOQ
  - IL6
  - CSF1
  - CCL2
  - CXCL12
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - IL18
  - HIF1A
  - SIRT1
  - NLRP3
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - PPARGC1A
  - IRF6
  - STAT3
  - FGF23
  - AKT2
  - AKT3
  - AKT1
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - CYP27B1
  - CYP24A1
  - EPAS1
  - PTH
  - XRCC1
  - SPDL1
  - ARNTL
  - HIF3A
  - ARNT
  - ARNT2
  - GSH
  - GSSG
  - Pentose Phosphate
  - Arginine
  - gluconate
  - Uric acid
  - NADPH
  - H
  - Glucose
  - phosphate
  - NADP
  - 2GSH
  - Cysteine
  - Citric
  - Pyruvate
  - glutamyl
  - cysteine
  - Glutamate
  - Metformin
  - Glycine
  - Ac
  - Lactate
  - Temsirolimus
  - Everolimus
  - ATP
  - oxalate
  - uric acid
  - 25(OH)
  - 1a-25(OH),D
  - OH
  - 25(OH)D
  - Axitinib
  - Cabozantinib
  - Pazopanib
  - Sorafenib
  - Sunitinib
  - Ca
  - Glomerulonephritis
  - Hypoxia
  - LPS
  - RCC
genes:
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: adiponectin,
  symbol: adiponectin
  source: hgnc_alias_symbol
  hgnc_symbol: ADIPOQ
  entrez: '9370'
- word: SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: M-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF1
  entrez: '1435'
- word: SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: SDF1
  source: hgnc_prev_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: CCL2,
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: SDF-1,
  symbol: SDF1
  source: hgnc_prev_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: M-CSF,
  symbol: M-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF1
  entrez: '1435'
- word: CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: SDF-1
  symbol: SDF1
  source: hgnc_prev_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: HIF-1a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: SIRT1
  symbol: SIRT1
  source: hgnc_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: (NLRP3)
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: PGC-1a
  symbol: PGC1A
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: ATP,LPS,oxalate
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: LPS,
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: HIF-1a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: FGF-23
  symbol: FGF23
  source: hgnc_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: CYP27B1
  symbol: CYP27B1
  source: hgnc_symbol
  hgnc_symbol: CYP27B1
  entrez: '1594'
- word: CYP24A1
  symbol: CYP24A1
  source: hgnc_symbol
  hgnc_symbol: CYP24A1
  entrez: '1591'
- word: HIF-2a
  symbol: HIF2A
  source: hgnc_alias_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: PTH
  symbol: PTH
  source: hgnc_symbol
  hgnc_symbol: PTH
  entrez: '5741'
- word: 'RCC:'
  symbol: RCC
  source: hgnc_prev_symbol
  hgnc_symbol: XRCC1
  entrez: '7515'
- word: adiponectin
  symbol: adiponectin
  source: hgnc_alias_symbol
  hgnc_symbol: ADIPOQ
  entrez: '9370'
- word: SPD-L1),
  symbol: SPDL1
  source: hgnc_symbol
  hgnc_symbol: SPDL1
  entrez: '54908'
- word: IncreasedEPO,PD-L1(&SPD-L1),oxidativestress,HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: IncreasedEPO,PD-L1(&SPD-L1),oxidativestress,HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: IncreasedEPO,PD-L1(&SPD-L1),oxidativestress,HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: IncreasedEPO,PD-L1(&SPD-L1),oxidativestress,HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: IncreasedEPO,PD-L1(&SPD-L1),oxidativestress,HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: IncreasedEPO,PD-L1(&SPD-L1),oxidativestress,HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: IncreasedEPO,PD-L1(&SPD-L1),oxidativestress,HIF,
  symbol: SPDL1
  source: hgnc_symbol
  hgnc_symbol: SPDL1
  entrez: '54908'
- word: HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: HIF,
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: CCL2,
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: SDF-1,
  symbol: SDF1
  source: hgnc_prev_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: M-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF1
  entrez: '1435'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: VEGF,SDF-1,M-CSF,IL-6,CCL2,IL-8
  symbol: SDF1
  source: hgnc_prev_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: M-CSF,
  symbol: M-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF1
  entrez: '1435'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
chemicals:
- word: GSH
  source: MESH
  identifier: D005978
- word: GSSG
  source: MESH
  identifier: D019803
- word: Pentose Phosphate
  source: MESH
  identifier: D010429
- word: Arginine
  source: MESH
  identifier: D001127
- word: gluconate
  source: MESH
  identifier: D005942
- word: Uric acid
  source: MESH
  identifier: D014527
- word: NADPH
  source: MESH
  identifier: D009249
- word: H
  source: MESH
  identifier: D006859
- word: Glucose
  source: MESH
  identifier: D005947
- word: phosphate
  source: MESH
  identifier: D010710
- word: NADP
  source: MESH
  identifier: D009249
- word: 2GSH
  source: MESH
  identifier: D005978
- word: Cysteine
  source: MESH
  identifier: D003545
- word: Citric
  source: MESH
  identifier: D019343
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: glutamyl
  source: MESH
  identifier: C097376
- word: cysteine
  source: MESH
  identifier: D003545
- word: Glutamate
  source: ''
  identifier: ''
- word: Metformin
  source: MESH
  identifier: D008687
- word: Glycine
  source: MESH
  identifier: D005998
- word: Ac
  source: MESH
  identifier: D000186
- word: Lactate
  source: MESH
  identifier: D019344
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Everolimus
  source: MESH
  identifier: C107135
- word: ATP
  source: MESH
  identifier: D000255
- word: oxalate
  source: MESH
  identifier: D010070
- word: uric acid
  source: MESH
  identifier: D014527
- word: 25(OH)
  source: MESH
  identifier: C104313
- word: 1a-25(OH),D
  source: MESH
  identifier: C101470
- word: OH
  source: MESH
  identifier: C031356
- word: 25(OH)D
  source: MESH
  identifier: C101470
- word: Axitinib
  source: MESH
  identifier: C503983
- word: Cabozantinib
  source: MESH
  identifier: C558660
- word: Pazopanib
  source: MESH
  identifier: C516667
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Sunitinib
  source: MESH
  identifier: C473478
- word: Ca
  source: MESH
  identifier: D002118
diseases:
- word: Glomerulonephritis
  source: MESH
  identifier: D005921
- word: Hypoxia
  source: MESH
  identifier: D000860
- word: LPS
  source: MESH
  identifier: C536528
- word: RCC
  source: MESH
  identifier: C538614
figid_alias: PMC7936245__F4
redirect_from: /figures/PMC7936245__F4
figtype: Figure
---
